Feedback / Questions
ALETA-001 - Aleta Biotherap
https://www.businesswire.com/news/home/20251208038512/en/Aleta-Biotherapeutics-and-Cancer-Research-UK-Announce-Promising-Phase-III-Data-from-ALETA-001-Clinical-Trial-for-Patients-With-RelapsedRefractory-B-Cell-Malignancies-Previously-Treated-with-CD19-CAR-T-Cell-Therapy
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next